• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ZC3H13 通过 PJA2 的 m6A 甲基化修饰和 KSR1 的泛素化促进膀胱癌中的自噬。

ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.

机构信息

Department of Urology, The First Affiliated Hospital of Bengbu Medical University, No. 287, Changhuai Road, Longzi Lake District, Bengbu, 233004, Anhui, People's Republic of China.

Department of Oncology, The First Affiliated Hospital of Bengbu Medical University, No. 287, Changhuai Road, Longzi Lake District, Bengbu, 233004, Anhui, People's Republic of China.

出版信息

Hum Cell. 2024 Nov 30;38(1):23. doi: 10.1007/s13577-024-01155-x.

DOI:10.1007/s13577-024-01155-x
PMID:39614918
Abstract

The N6-methyladenine (m6A) modification is the most common modification of messenger RNAs in eukaryotes and has crucial roles in multiple cancers, including bladder cancer (BLCA). This paper aimed to probe the molecular mechanism of zinc-finger CCCH-type containing 13 (ZC3H13)-mediated N6-methyladenine (m6A) modification in BLCA progression via autophagy. Differential expression of ZC3H13 in BLCA was analyzed by the bioinformatics database. ZC3H13 expression in BLCA tissues and cell lines was determined, and malignant behaviors of BLCA cells were examined in vitro and in vivo. ZC3H13 was decreased in BLCA tissues and cell lines relative to adjacent tissues and normal uroepithelial cells. ZC3H13 overexpression restricted BLCA cell growth in vitro and curbed BLCA development in vivo. ZC3H13 promoted the mRNA stability of paraja ring finger 2 (PJA2) through m6A modification, leading to the ubiquitination degradation of the kinase suppressor of Ras 1 (KSR1). Knockdown of PJA2 and overexpression of KSR1 reversed the inhibitory effect of ZC3H13 on BLCA progression. ZC3H13 degraded KSR1 through m6A modification of PJA2, promoted cell autophagy, and repressed BLCA progression. Overall, ZC3H13 promotes the mRNA stability of PJA2 through m6A modification to degrade KSR1, thereby promoting autophagy in BLCA.

摘要

N6-甲基腺嘌呤(m6A)修饰是真核生物信使 RNA 中最常见的修饰,在多种癌症中具有重要作用,包括膀胱癌(BLCA)。本文旨在通过自噬探讨锌指 CCCH 型包含 13(ZC3H13)介导的 BLCA 进展中 N6-甲基腺嘌呤(m6A)修饰的分子机制。通过生物信息学数据库分析 BLCA 中 ZC3H13 的差异表达。测定 BLCA 组织和细胞系中 ZC3H13 的表达,并在体外和体内检测 BLCA 细胞的恶性行为。与相邻组织和正常尿路上皮细胞相比,BLCA 组织和细胞系中 ZC3H13 的表达降低。ZC3H13 过表达限制了 BLCA 细胞在体外的生长,并抑制了 BLCA 细胞在体内的发育。ZC3H13 通过 m6A 修饰促进了 paraja 环指 2(PJA2)的 mRNA 稳定性,导致 Ras 激酶抑制剂 1(KSR1)的泛素化降解。PJA2 的敲低和 KSR1 的过表达逆转了 ZC3H13 对 BLCA 进展的抑制作用。ZC3H13 通过 PJA2 的 m6A 修饰降解 KSR1,促进细胞自噬,抑制 BLCA 进展。总之,ZC3H13 通过 m6A 修饰促进 PJA2 的 mRNA 稳定性,从而降解 KSR1,促进 BLCA 中的自噬。

相似文献

1
ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.ZC3H13 通过 PJA2 的 m6A 甲基化修饰和 KSR1 的泛素化促进膀胱癌中的自噬。
Hum Cell. 2024 Nov 30;38(1):23. doi: 10.1007/s13577-024-01155-x.
2
ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis.ELK4 通过调节 KDM5A-PJA2-KSR1 轴诱导巨噬细胞 M2 极化促进胃癌的发展。
J Transl Med. 2021 Aug 9;19(1):342. doi: 10.1186/s12967-021-02915-1.
3
ZC3H13 Accelerates Keloid Formation by Mediating N-methyladenosine Modification of HIPK2.ZC3H13 通过调控 HIPK2 的 N6-甲基腺苷化修饰促进瘢痕疙瘩形成。
Biochem Genet. 2024 Jun;62(3):1857-1871. doi: 10.1007/s10528-023-10514-6. Epub 2023 Sep 26.
4
ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2.ZC3H13 通过调控 CKAP2 的 m6A 修饰增强宫颈癌的恶性程度。
Crit Rev Immunol. 2023;43(6):1-13. doi: 10.1615/CritRevImmunol.2023049342.
5
ZC3H13-induced the m6A modification of hsa_circ_0081723 promotes cervical cancer progression via AMPK/p53 pathway.ZC3H13 诱导 hsa_circ_0081723 的 m6A 修饰通过 AMPK/p53 通路促进宫颈癌进展。
J Obstet Gynaecol Res. 2024 Dec;50(12):2286-2298. doi: 10.1111/jog.16140. Epub 2024 Oct 30.
6
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.METTL16 通过自噬途径以 m6A 方式降解 PMEPA1 mRNA 抑制膀胱癌的增殖和顺铂化疗耐药性。
Int J Biol Sci. 2024 Feb 4;20(4):1471-1491. doi: 10.7150/ijbs.86719. eCollection 2024.
7
hsa_circ_0101050 regulated by ZC3H13 enhances tumorigenesis in papillary thyroid cancer via mA modification.由ZC3H13调控的hsa_circ_0101050通过mA修饰增强甲状腺乳头状癌的肿瘤发生。
Heliyon. 2024 Jun 13;10(12):e32913. doi: 10.1016/j.heliyon.2024.e32913. eCollection 2024 Jun 30.
8
ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification.ZC3H13 通过 m6A 依赖性修饰减少喉鳞状细胞癌细胞中 DUOX1 介导的铁死亡。
Tissue Cell. 2023 Oct;84:102187. doi: 10.1016/j.tice.2023.102187. Epub 2023 Jul 29.
9
Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.ZC3H13 的过表达通过 m6A 修饰介导的 IQGAP1 降解抑制甲状腺乳头状癌的生长。
J Formos Med Assoc. 2023 Aug;122(8):738-746. doi: 10.1016/j.jfma.2022.12.019. Epub 2023 Feb 2.
10
The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury.在顺铂诱导的急性肾损伤中,抑制ZC3H13可通过减轻NABP1的m6A修饰来减弱G2/M期阻滞和细胞凋亡。
Cell Mol Life Sci. 2025 Feb 22;82(1):86. doi: 10.1007/s00018-025-05596-x.

引用本文的文献

1
Emerging role of RNA m6A modifications in laryngeal squamous cell carcinoma: insights into tumorigenesis and therapeutic potential.RNA m6A修饰在喉鳞状细胞癌中的新兴作用:对肿瘤发生和治疗潜力的见解
Apoptosis. 2025 Aug 14. doi: 10.1007/s10495-025-02159-0.

本文引用的文献

1
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma.m6A RNA 甲基化调控因子在乙型肝炎病毒相关肝细胞癌诊断及亚型分类中的意义。
Hum Cell. 2024 May;37(3):752-767. doi: 10.1007/s13577-024-01044-3. Epub 2024 Mar 27.
2
RNA N-methyladenosine modifications in urological cancers: from mechanism to application.尿路上皮癌中 RNA N6-甲基腺嘌呤修饰:从机制到应用。
Nat Rev Urol. 2024 Aug;21(8):460-476. doi: 10.1038/s41585-023-00851-x. Epub 2024 Feb 12.
3
Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression.
基于凋亡相关基因建立膀胱癌预后模型,其中 P4HB 促进 BLCA 进展。
BMC Urol. 2023 Oct 16;23(1):167. doi: 10.1186/s12894-023-01331-5.
4
Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy.解析 RAS/RAF/MEK/ERK 信号通路与癌症自噬的相互作用:从分子机制到靶向治疗。
Biochem Pharmacol. 2023 Nov;217:115842. doi: 10.1016/j.bcp.2023.115842. Epub 2023 Oct 5.
5
Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells.RAS 信号通路的激酶抑制因子 1(KSR1)维持 BRAFV600E 突变型人黑色素瘤细胞的转化表型。
Int J Mol Sci. 2023 Jul 23;24(14):11821. doi: 10.3390/ijms241411821.
6
Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade.Stellettin B 通过激活自噬/ DAPK2/凋亡信号级联诱导膀胱癌细胞死亡。
Mar Drugs. 2023 Jan 21;21(2):73. doi: 10.3390/md21020073.
7
Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.ZC3H13 的过表达通过 m6A 修饰介导的 IQGAP1 降解抑制甲状腺乳头状癌的生长。
J Formos Med Assoc. 2023 Aug;122(8):738-746. doi: 10.1016/j.jfma.2022.12.019. Epub 2023 Feb 2.
8
Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer.用于预测乳腺癌预后及评估免疫特征的m6A相关基因特征的鉴定与验证
Hum Cell. 2023 Jan;36(1):393-408. doi: 10.1007/s13577-022-00826-x. Epub 2022 Nov 20.
9
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.m6A RNA甲基化在癌症中的作用:对天然产物抗癌研究的启示
Front Pharmacol. 2022 Jun 16;13:933332. doi: 10.3389/fphar.2022.933332. eCollection 2022.
10
Hidden codes in mRNA: Control of gene expression by mA.mRNA 中的隐藏代码:mA 对基因表达的控制。
Mol Cell. 2022 Jun 16;82(12):2236-2251. doi: 10.1016/j.molcel.2022.05.029.